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ABSTRACT 
Background: The aim was to complete a feasibility study that would test the methods of the 
main trial, that will investigate whether early thoracic and shoulder girdle exercises reduce 
chronic pain in patients with blunt chest wall trauma, when compared to normal care. 
Methods: A single centre, parallel, feasibility randomised controlled trial was completed at a 
University Teaching Hospital in Wales between June and September 2019. Adult patients 
with blunt chest wall trauma, admitted to hospital for greater than 24 hours, with no 
concurrent, immediately life-threatening injuries, were included. The intervention was a 
simple physiotherapy programme comprising thoracic and shoulder girdle exercises. 
Feasibility outcome measures included: 1) 80% or more of identified eligible patients were 
approached for potential recruitment to the trial 2) 30% or less of approached, eligible 
patients dissented to participate in the trial; secondary outcomes: 3) follow up data for 
patient secondary outcomes can be collected for 80% or more of patients, 4) there should be 
no greater than 10% increase in serious adverse events in the intervention group compared 
to the control group.  
Results: A total of 19/19 (100%) patients were deemed eligible for the trial and were 
approached for participation, 5/19 (26%) eligible patients declined to participate in the trial, 
follow-up data was collected for n=10/14 (71%) patients and there were no serious adverse 
events reported in either group.  
Conclusions: We have demonstrated that a fully powered randomised clinical trial of the 
ELECT Trial is feasible.  
 
ISRCTN Trial registration number:  ISRCTN 16197429. Date registered: 29th May 2019. 
https://www.isrctn.com/ISRCTN16197429.  
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What is already known on this subject? 
Blunt chest trauma is a difficult condition to manage and many patients report chronic pain at 
three months post-injury.  
What this study adds? 
This feasibility study has demonstrated that a fully powered randomised clinical trial 
investigating the effectiveness of an early exercise programme for patients with blunt chest 
wall trauma is feasible. 
 
BACKGROUND 
Blunt chest wall trauma accounts for over 15% of all trauma admissions worldwide, with 
reported mortality ranging between 4 and 60%.[1] Chronic pain and disability have been 
reported in 62% and 57% of patients at 3 months post injury respectively.[2] Physiotherapy 
rehabilitation is recommended as part of multi-disciplinary approach to the management of 
blunt chest trauma, but evidence-based protocols are lacking.[3] Further research is needed 
into the optimal management of chronic pain and disability. The aim of this trial was to 
establish the feasibility and acceptability of a future definitive trial, which will determine 
whether an exercise programme can be used safely and effectively used to reduce chronic 
pain in blunt chest wall trauma, in clinical practice in the UK. 
 
METHODS 
This trial received ethics approval by the Wales Research Ethics Committee 6 (Ref: 19-WA-
0144). This study adhered to the CONSORT extension guidelines for pilot and feasibility 
trials.  
 
Trial design and randomisation  
This was a single-centre, parallel feasibility randomised controlled trial, initiated in a trauma 
unit in Wales, over a three month period (June to September 2019). Patients were allocated 
4 
 
to the trial on a 1:1 ratio to control or intervention arms, using “Sealed Envelope”, an 
independent on-line randomisation software company which is available 24 hours per day.[4]  
 
Population 
Patients admitted to the hospital for 24 hours or more, with isolated blunt chest wall trauma 
(defined as blunt chest wall injury, with or without radiologically confirmed rib fractures), were 
included in the trial if they were capable of giving consent to participation and aged 18 and 
over. Exclusion criteria included: patients lacking capacity to provide informed consent, aged 
under 18, or presenting with immediately life-threatening injuries or any concurrent injury 
precluding participation in the intervention (patients with minor injuries not precluding 
participation, such as a concurrent knee ligament injury, were not excluded)  
 
Sample size  
The trial had a three-month recruitment period. The aim was to recruit 20 patients, the 
minimum number considered necessary to test data collection processes based on existing 
recommendations.[5]  
 
Intervention 
Patients were identified by the hospital’s physiotherapy-led chest trauma team, who 
undertook consent and randomisation. Patients allocated to the intervention group, received 
standard care (where standard care traditionally involves chest physiotherapy techniques 
such as breathing exercises and early mobilisation), in addition to a programme of thoracic / 
shoulder girdle exercises (delivered by the physiotherapist who would routinely manage the 
patient as part of standard care). This programme was continued by the patient, three times 
per day, for seven days post-assessment. The exercise programme consisted of shoulder 
active range of movement exercises  trunk active side-flexion, rotation, forward flexion and 
extension range of movement exercises (all within limits of pain). Participants were 
instructed to complete each exercise five times, per session. (See Additional file 1 for 
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exercise programme). Patients were asked to record adherence to the programme, on the 
back of the exercise programme. The control group received standard care only.  
 
All participants were asked to complete the Euroqol Quality of Life survey (EQ5D-5L)[6] on 
initial presentation and two more surveys at three months (EQ5D-5L and the Brief Pain 
Inventory (BPI)).[7] One survey was posted to the patients at three months, followed by a 
telephone contact if the postal survey was not received by the research team within two 
weeks.  
 
Criteria for establishing feasibility 
In order to evaluate the feasibility of a full definitive trial, the trial results were assessed 
against predetermined success outcome criteria  using a traffic light system[8], Primary: 1) 
adherence to the trial protocol by the physiotherapy team and 2) acceptability of the 
intervention by the patients.  Secondary: 1) ability to retrieve follow up data and 2)  safety of 
the intervention measured by number of serious adverse events. 
 
Data analysis 
Analysis was performed on SPSS (Version 23; IBM, Armonk, NY, USA) using the intention-
to-treat principle. Analysis was not powered to detect clinically important effects, as this was 
a feasibility trial. Results are presented as numbers (percentages), means (standard 
deviations), and medians (interquartile ranges) where non-normally distributed.  
 
Patient and public involvement 
Two patients recovering from recent blunt chest trauma were members of the ELECT Trial 
Development Group (TDG) that developed the protocol, specifically advising on the content  
and delivery of the exercise programme, design of patient-facing documents and methods 
for follow-up. They continued to sit on the Trial Management Group (TMG), attending 
research meetings and contributing to the overall running of the trial. Moving forward to the 
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main trial, the patient representatives will continue to advise on design of patient-facing 
documents, protocol modification based on this feasibility and on-going analysis of trial 
results.  
 
RESULTS 
Patients were recruited over the three month period (June to Sept 2019) and there were no 
difficulties implementing the protocol. A total of 14 patients were recruited (Figure 1). Loss to 
follow-up was 2 out of 7 (29%) patients per arm. In the intervention group, patients reported 
completing a mean of 79% (range 62%-100%) of the exercise programme. No issues were 
reported by patients completing the exercises, in terms of difficulty completing the 
programme, serious adverse events or increased levels of pain as a result of the exercise.    
 
The intervention and control groups were mostly comparable at baseline, although hospital 
length of stay appears longer in the intervention group (Table 1).  
 
Table 1. Baseline Characteristics 
 Total (n=14) Control (n=7) Intervention (n=7) 
Age (years) 75 (70-80) 75 (71-86) 72 (60-80) 
Male  10 (71%) 4 (29%) 6 (43%) 
Female 4 (29%) 3 (21%) 1 (7%) 
Number of rib fractures (median/IQR) 4 (3-7) 4 (3-8) 4 (3-6)  
Flail chest 4 (29%) 2 (14%) 2 (14%) 
Injury mechanism:    
• Fall <2 metres 6 (43%) 4 (29%) 2 (14%) 
• Fall >2 metres 4 (29%) 1 (7%) 3 (21%) 
• Road traffic accident 4 (29%) 2 (14%) 2 (14%) 
Underlying lung injury:    
• Pulmonary contusion 1 (7%) 1 (7%) 0 (0%) 
• Haemothorax 3 (21%) 1 (7%) 2 (14%) 
• Pneumothorax 4 (29%) 2 (14%) 2 (14%) 
Intercostal chest drain 2 (14%) 0 (0%) 2 (14%) 
Highest level of care:     
• Intensive Care 2 (14%) 2 (14%) 0 (%) 
• High dependency 4 (29%) 2 (14%) 2 (14%) 
• Ward 8 (57%) 3 (21%) 5 (36%) 
Complications    
• Type 1 respiratory failure 2 (14%) 0 (0%) 2 (14%) 
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• Type 2 respiratory failure 1 (7%) 0 (0%) 1 (7%) 
Mechanical ventilation 0 (0%) 0 (0%) 0 (0%) 
ICU length of stay 0 (0-1) 0 (0-1) 0 (0-1) 
Total hospital length of stay 8 (4-15) 4 (2-10) 10 (7-17) 
Discharged home 14 (100%) 7 (100%) 7 (100%) 
Number (%), median (IQR) 
 
Feasibility criteria 
All pre-set feasibility criteria achieved a green or amber status (Table 2). A mixture of postal 
and telephone follow up contacts were required for survey completion at three months.  
Table 2: Feasibility outcomes 
 
Feasibility Criteria  Result Feasibility assessment 
Primary outcomes   
1) 80% or more of identified eligible patients 
were approached for potential recruitment to 
the trial  
n=19/19 (100%) patients were 
deemed eligible for the trial and 
were approached for participation  
GREEN 
2) 30% or less of approached, eligible patients 
dissented to participate in the trial 
n=5/19 (26%) eligible patients 
declined to participate in the trial 
GREEN 
Secondary outcomes   
3) Follow up data for patient secondary 
outcomes can be collected for 80% or more of 
patients 
Follow-up data collected for 
n=10/14 (71%) of patients 
AMBER 
4) There should be no greater than 10% 
increase in serious adverse events in the 
intervention group compared to the control 
group 
There were no serious adverse 
events reported in either group 
GREEN 
number of cases (percent). Feasibility criteria traffic light system: GREEN: feasibility criteria achieved, AMBER: 
feasibility criteria not achieved, but progression is possible with some minor protocol modifications, RED: 
Feasibility criteria not achieved and progression to a full trial is not possible 
 
 
 
DISCUSSION 
Although pre-set feasibility criteria were met, this feasibility trial has highlighted some 
additional minor modifications (not included in original feasibility criteria) that need to be 
made to the methods prior to moving forward to the full trial. Specifically, the recruitment rate 
was lower than expected as the trial ran over a three month period in the summer, however 
this data will inform the length of time needed for recruitment in the main trial. We will also 
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need to consider strategies for ensuring optimal recruitment of all potential patients and 
minimising attrition.  
 
There were a number of limitations in this feasibility study. We did not include adherence to 
the programme as a progression criteria. This could have been a potential variable 
precluding progression to full trial, however the reported adherence (mean of 79% of 
exercise programme completed) suggested that progression to full trial is feasible.  The 
lower than planned recruitment rate was also a limitation of the trial, however we will be able 
to conduct a more accurate sample size, with this knowledge, moving forward to the full trial. 
A qualitative analysis was not completed due to limited funding, but will be included in the full 
trial. In addition, we will also need to consider the fidelity of intervention delivery, once more 
sites and physiotherapists are involved.  
 
In conclusion, this work has demonstrated that with some minor modifications, progression 
to the full definitive impact trial is feasible.  
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